In the current study, we investigated the expression pattern of TIGIT in NK cells derived from bone marrow specimens of newly diagnosed CBF-AML patients and analyzed its impacts on NK cell function and patient outcomes. Here, TIGIT is linked to acute myeloid leukemia.